These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38847319)

  • 1. Describing Elephants: An Update on the Immunopathology of Multisystem Inflammatory Syndrome in Children.
    van den Berg S; Sun T
    Immunol Invest; 2024 Aug; 53(6):962-974. PubMed ID: 38847319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
    Noval Rivas M; Porritt RA; Cheng MH; Bahar I; Arditi M
    Front Immunol; 2022; 13():941009. PubMed ID: 35874696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.
    Porritt RA; Paschold L; Rivas MN; Cheng MH; Yonker LM; Chandnani H; Lopez M; Simnica D; Schultheiß C; Santiskulvong C; Van Eyk J; McCormick JK; Fasano A; Bahar I; Binder M; Arditi M
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33705359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
    Conway SR; Lazarski CA; Field NE; Jensen-Wachspress M; Lang H; Kankate V; Durkee-Shock J; Kinoshita H; Suslovic W; Webber K; Smith K; Cohen JI; Burbelo PD; Zhang A; Teach SJ; Ibeh T; Delaney M; DeBiasi RL; Keller MD; Bollard CM
    Front Immunol; 2021; 12():793197. PubMed ID: 35116027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study.
    Lawrence DA; Jadhav A; Mondal TK; Carson K; Lee WT; Hogan AH; Herbst KW; Michelow IC; Brimacombe M; Salazar JC; The Connecticut Children's Covid Collaborative
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.
    Yonker LM; Gilboa T; Ogata AF; Senussi Y; Lazarovits R; Boribong BP; Bartsch YC; Loiselle M; Rivas MN; Porritt RA; Lima R; Davis JP; Farkas EJ; Burns MD; Young N; Mahajan VS; Hajizadeh S; Lopez XIH; Kreuzer J; Morris R; Martinez EE; Han I; Griswold K; Barry NC; Thompson DB; Church G; Edlow AG; Haas W; Pillai S; Arditi M; Alter G; Walt DR; Fasano A
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34032635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
    Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
    Anderson EM; Diorio C; Goodwin EC; McNerney KO; Weirick ME; Gouma S; Bolton MJ; Arevalo CP; Chase J; Hicks P; Manzoni TB; Baxter AE; Andrea KP; Burudpakdee C; Lee JH; Vella LA; Henrickson SE; Harris RM; Wherry EJ; Bates P; Bassiri H; Behrens EM; Teachey DT; Hensley SE
    J Pediatric Infect Dis Soc; 2021 May; 10(5):669-673. PubMed ID: 33263756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
    Costagliola G; Spada E; Consolini R
    Immun Inflamm Dis; 2021 Jun; 9(2):331-339. PubMed ID: 33566457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19.
    Parums DV
    Med Sci Monit; 2021 Oct; 27():e935005. PubMed ID: 34629462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children.
    Porritt RA; Binek A; Paschold L; Rivas MN; McArdle A; Yonker LM; Alter G; Chandnani HK; Lopez M; Fasano A; Van Eyk JE; Binder M; Arditi M
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34437303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C).
    Henderson LA
    Adv Exp Med Biol; 2024; 1448():409-425. PubMed ID: 39117830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
    Ramaswamy A; Brodsky NN; Sumida TS; Comi M; Asashima H; Hoehn KB; Li N; Liu Y; Shah A; Ravindra NG; Bishai J; Khan A; Lau W; Sellers B; Bansal N; Guerrerio P; Unterman A; Habet V; Rice AJ; Catanzaro J; Chandnani H; Lopez M; Kaminski N; Dela Cruz CS; Tsang JS; Wang Z; Yan X; Kleinstein SH; van Dijk D; Pierce RW; Hafler DA; Lucas CL
    Immunity; 2021 May; 54(5):1083-1095.e7. PubMed ID: 33891889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of SARS-CoV-2 infection in children.
    Chou J; Thomas PG; Randolph AG
    Nat Immunol; 2022 Feb; 23(2):177-185. PubMed ID: 35105983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.
    Sharma C; Ganigara M; Galeotti C; Burns J; Berganza FM; Hayes DA; Singh-Grewal D; Bharath S; Sajjan S; Bayry J
    Nat Rev Rheumatol; 2021 Dec; 17(12):731-748. PubMed ID: 34716418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper.
    Feleszko W; Okarska-Napierała M; Buddingh EP; Bloomfield M; Sediva A; Bautista-Rodriguez C; Brough HA; Eigenmann PA; Eiwegger T; Eljaszewicz A; Eyerich S; Gomez-Casado C; Fraisse A; Janda J; Jiménez-Saiz R; Kallinich T; Krohn IK; Mortz CG; Riggioni C; Sastre J; Sokolowska M; Strzelczyk Z; Untersmayr E; Tramper-Stranders G;
    Pediatr Allergy Immunol; 2023 Jan; 34(1):e13900. PubMed ID: 36705045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.